Multiphase adjuvant neuroprotection: A novel paradigm for improving acute ischemic stroke outcomes.
Wenbo Zhao, Chuanjie Wu, David Dornbos...
https://pubmed.ncbi.nlm.nih.gov/32166195/Actively Recruiting
Led by Capital Medical University · Updated on 2025-12-10
2105
Participants Needed
56
Research Sites
13 weeks
Total Duration
Researchers are studying patients who have had an acute ischemic stroke caused by a blockage in a large blood vessel in the brain. The trial focuses on the safety and effectiveness of remote ischemic conditioning RIC as an additional treatment to improve recovery after endovascular thrombectomy, a procedure that removes the blockage. This research addresses the challenge that even when blood flow is restored, many patients still have poor outcomes or die, possibly due to brain injury during and after the procedure. The study compares three groups one receiving only endovascular thrombectomy and best medical care, a second group receiving thrombectomy plus RIC treatment for 14 days, and a third group receiving thrombectomy plus RIC for 30 days. RIC is a noninvasive device treatment where a cuff on the upper arm inflates and deflates in cycles, applied once before thrombectomy and twice daily afterward. Best medical management follows clinical guidelines for all groups. Participants will be monitored closely for 90 days after stroke. Researchers will assess recovery using the modified Rankin Scale to measure functional independence and will record neurological improvements, brain infarct size, adverse events, and quality of life. The study includes imaging, neurological exams, and safety checks at multiple time points, including 24 hours, 14 days, 72 hours, and 90 days post-treatment to evaluate the impact of RIC on stroke outcomes.
CONDITIONS
Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy(RECAST-MT)
X
Xunming Ji, MD, PhD
S
Sijie Li, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Capital Medical University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 30 days post-thrombectomy
Participants receive endovascular thrombectomy to recanalize the blocked vessel. Depending on their group, participants may also undergo remote ischemic conditioning once before thrombectomy and twice daily for 14 or 30 days post-thrombectomy, along with best medical management according to guidelines.
Daily visits for up to 30 days post-thrombectomy
Duration - Up to 90 days after stroke
Participants are followed up to assess neurological improvement, safety outcomes, and overall recovery up to 90 days after stroke.
Visits at 24 hours, 72 hours, 14 days, and 90 days after thrombectomy
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Wenbo Zhao, Chuanjie Wu, David Dornbos...
https://pubmed.ncbi.nlm.nih.gov/32166195/Jia-Qi An, Ya-Wen Cheng, Yi-Chen Guo...
https://pubmed.ncbi.nlm.nih.gov/33028663/Yongle Wang, Shuangfeng Huang, Lan Liu...
https://pubmed.ncbi.nlm.nih.gov/41290408/Wenbo Zhao, Ran Meng, Chun Ma...
https://pubmed.ncbi.nlm.nih.gov/28174194/Capital Medical University
Lead Sponsor